Introduction
evolution of the process toward dysfunction and failure. Furthermore, some new attempts to modify the conseIn 1977 Sen, Tarazi and Bumpus in a brief article in quence of myocardial hypertrophy or to prevent myocyte Cardiovascular Research discussed the variable effects cell loss will be also examined to document the difficulties obtained with anti-hypertensive therapy on cardiac hythat we are still facing more than 20 years after the pioneer pertrophy and its regression [1] . Having the aim of study of Sen at al. [1] . A complete review of the argument, intervening with medical treatment on cardiac hypertrophy however, is beyond the aim of this article. the authors attained results quite different from the expected one. Although this event is very common in research the authors were able to take advantage from the 2. Definition discrepancy suggesting new hypotheses, possible explanations and innovating conclusions. They found that in Since cardiac hypertrophy is a condition in which spontaneous hypertensive rats (SHR), an animal model that myocardial mass is increased beyond the normal range, the mimics essential hypertension in humans, the vasodilator establishment of normal and abnormal limits is needed in a-methyldopa was able to reduce blood pressure, renin order to define the presence and the degree of this disease. activity and reverse cardiac hypertrophy, whereas minoxAnatomical studies (Figs. 1 and 2) have demonstrated that idil another vasodilator reduced blood pressure, increased the upper limit of a normal heart is 450 g in men and 400 g heart weight and renin activity. Finally, beta blockade not in women [2] . These values, however, must be corrected affecting blood pressure, reduced cardiac mass and renin for epicardial fat, body mass and age [2] . In both genders, activity. These results highlighted the uncertainty in the left ventricular myocardial weight to body height ratio relation between cardiac hypertrophy, arterial blood pressure levels and renin, implying that blood pressure 'may not be the sole factor for the development and reversal of cardiac hypertrophy'. Today, more than 20 years after the publication of this article there is evidence that these ideas are of relevance and extremely important to understanding the mechanisms involved in the development and progression of cardiac hypertrophy. This is also demonstrated by the large number of quotations of this article in the following years.
In this review the results obtained in human and some animal models of cardiac hypertrophy will be summarized in the attempt to illustrate the complexity of the phenomena implicated in the hypertrophy of the heart and the *Corresponding author. Tel.: 139-0521-29-0386; fax: 139-0521-29- Fig. 1 . Photomicrograph of a normal human heart of 350 g in weight 2710.
from a 35-year-old male who died by accident. Bar indicates 2 cm in E-mail address: olivetti@ipruniv.cce.unipr.it (G. Olivetti) length.
0008-6363 / 00 / $ -see front matter © 2000 Elsevier Science B. V. All rights reserved. PII: S0008-6363( 99 )00298-9 chamber enlargement [4] . Reactive compensatory hypertrophy after myocyte cell loss, i.e. in non-infarcted portion of the heart following an acute myocardial infarction [5] , is characterized by different degrees of myocyte lengthening and widening [6] . Early on, after the imposition of the stimulus, a well balanced response occurs and the hypertrophied heart is characterized by a constant wall thickness-to-chamber radius or myocardial mass-tochamber volume ratio. These patterns of growth may vary with type, magnitude and duration of the inciting stimulus, sex, age, diet, hormonal and environmental influences and concomitant diseases. Furthermore, in patients with genetic cardiomyopathies, myocardial hypertrophy develops without external stimuli [7] . The hypertrophic growth of the heart, when challenged by increased work demand, has commonly considered a agreement with a cut-off limit of 50 g / m used to risk factor for cardiovascular morbidity and mortality [8], separate normal from hypertrophied hearts by echocardiogis associated with an increased frequency of ventricular raphy [3] .
arrhythmias in the absence of coronary artery disease [9] Different causes may produce cardiac hypertrophy but in and has a negative impact on survival more in females than general, it occurs in response to an overload. When the in males [10] . These results are consistent with anatomical working load increases, myocytes enlarge (Fig. 3) until the studies demonstrating that chamber enlargement and venstress per cell returns to normal. However, myocyte tricular thinning are present in concomitance with impairlengthening with addition of new sarcomeres in series is ment in ventricular function in decompensated ventricular the prevailing mechanism following volume overloads, i.e.
hypertrophy [11, 12] . The terminal phase of this process is eccentric hypertrophy, in which ventricular chamber dilatathe end-stage cardiac failure which still represents nowation is accompanied by a proportional increase in wall days, a very common cardiac disorder with an unfavorable thickness. Lateral expansion of myocytes with the addition outcome [13, 14] . Thus, cardiac hypertrophy per se cannot of new sarcomeres in parallel represents the typical pattern be considered a physiological process and seems to contain of myocyte growth after pressure overload, i.e. concentric maladaptive changes which affect the short and long-term hypertrophy, in which wall thickness increases with minor prognosis. Irrespective of mechanisms and loading conditions, the evolution of cardiac hypertrophy to ventricular dysfunction is an irreversible on-going process dependent upon several factors, among them the duration of the overload appears to be one of the more significant parameters. Additionally, several studies have suggested that loss of contractile cells, the consequent amount of reparative tissue, and the extent of growth of the remaining cardiomyocytes are major components for the remodeling of the hypertrophied heart and for the transition from a well compensated myocardial growth to a decompensated heart. Thus, any attempt to attenuate myocyte growth is justified and should be performed before the occurrence of myocyte cell loss with the hope to maintain heart dimensions within a normal range. by a significant loss of myocytes and reactive hypertrophy of the remaining viable cells [2, 15] . Furthermore, gender differences exist in the remodeling of the heart with age. Myocardial weight remained essentially constant in women and decreased with time in men [2] . In women, the number of mononucleated and binucleated myocytes in the left and right ventricles is constant from 20 to 95 years of age. In contrast, the heart of a 20-year-old man contains approxi- independent from hormonal changes. In any case, women are less frequently affected by cardiovascular events and have a greater capacity to sustain an hemodynamic oversulting in overt left ventricular failure and right ventricular load with age [16] [17] [18] . Interestingly, gender-dependent dysfunction at the latest interval examined [25] . It should differences in left ventricular mass and function with aging be noted that in the Fischer 344 animal model, myocardial have been found in rat hearts [19] and early and late injury, in the form of multiple foci of replacement fibrosis, responses of the heart to a pressure overload are distincincreases in the ventricle as a function of age and myocyte tively better in female than in male rats [20] .
hypertrophy and proliferation occur in response to myocyte Although the mechanism responsible for myocyte cell cell death [15, 25] . These alterations, together with mural death with aging has not been identified yet, defects in thinning, chamber dilatation and elevated transmural circoronary vasculature may lead to ischemic myocytolytic cumferential stress, contribute substantially to the developnecrosis [21] . Recently, programmed cell death has been ment of decompensated ventricular hypertrophy seen in the detected in adult myocytes of humans and animals and this senescent rat heart. condition may be considered to be part of the aging In summary, the aging heart is characterized by progresprocess of the heart [22,23]. Apoptosis, a term often used sive loss of myocytes by apoptosis and necrosis, hyas a synonymous for programmed cell death, is characterpertrophy of the remaining myocytes and extensive reparaized by the activation of an endogenous endonuclease that tive processes. All these structural changes can contribute results in a regular pattern of DNA degradation in oligonuto limit the capacity of the aged heart to sustain an cleosomes. This characteristic type of DNA cleavage can increased workload. The female heart, however, seems to be demonstrated morphologically by the terminal deoxynube protected from these events. These observations confirm cleotydil transferase (TdT) assay (Fig. 4) and biochemicalthe original statement of Sen et al. [1] that the hypertrophy ly by agarose gel electrophoresis. Monoclonal antibody to of the heart may be independent from the load and cardiac myosin injected in vivo, was also used to detect underscore the possibility that the hypertrophic growth and measure necrotic myocyte cell death in the myocarmay be present exclusively at the cellular level independium [24] . The antibody can reach the intracellular antigen dently from the changes visible at the organ level. only in the presence of irreversible damage of the sarcolemmal membrane in necrotic myocytes.
These methods have been used to measure the different 4. Induced cardiac hypertrophy contribution of necrotic and apoptotic myocyte cell death with aging in Fischer 344 rats [23] . Myocyte necrosis
In the early stages of pressure overload induced cardiac involved 1300 myocytes in the left ventricle and septum hypertrophy or in SHR, no significant structural changes or combined at 3 months of age reaching a value of 23 000 at myocardial damage were detectable, despite significant 24 months. In the right ventricle there were 270 necrotic growth of the contractile component [26, 27] . However, myocytes at 3 months and 9000 at 24 months. Apoptotic shortly after an abrupt increase in afterload by ascending myocyte cell death was restricted to the left ventricle and aortic banding, myocyte cell loss by apoptosis was deincluded 140 cells at 3 months and 874 myocytes at 24 tected [28] . A long-term (5-6 months) slowly developing months. These morphological changes were associated pressure overload imposed on the right ventricle disclosed with a progressive decrease in ventricular function, remyocyte hypertrophy and hyperplasia, capillary prolifer-ation and an increased number of mastcells within the tissue [29] [30] [31] . In contrast, long-term one-kidney-one-clip renal hypertension is characterized by elevation in left ventricular end-diastolic pressure, ventricular chamber dilatation, thinning of the wall, extensive myocardial damage in the form of scattered areas of replacement fibrosis and myocyte hypertrophy and hyperplasia [32, 33] . Similarly, myocardial structure in old SHR is modified by the presence of large areas of replacement fibrosis across the left ventricular wall [34] . In old SHR these anatomical and structural findings are associated with several indexes of congestive heart failure [35] and an increased propensity to arrhythmogenesis [34] . The alterations described above may be carefully considered in the interpretation of the The risk to develop congestive heart failure in humans with hypertension and cardiac hypertrophy is elevated [36] . However, there is no definite answer to explain this remained unchanged. Additionally, in ischemic carominous outcome. It is well known that coronary vascular diomyopathies an average 28% and 13% collagen accumugrowth is limited in animals and humans with pressurelation ( Fig. 5 ) was found in the left and right ventricular induced cardiac hypertrophy [37, 38] , and severe ischemia myocardium, respectively [44] and in dilated carresulting in myocardial infarction is present in half the diomyopathies myocardial scarring represented almost patients with hypertension [36] . These observations appear 20% of ventricular myocardium [43] . This degree of to support the concept that hypertrophied myocytes are fibrotic tissue, indicative of a large amount of myocyte cell more prone to ischemia than normal cells. However, other loss, may explain the limited possibility to improve cardiac factors may be operative. Myocardial remodeling in severe function in these hearts. cardiac hypertrophy in humans differs in relations to However, compelling evidence from the results obtained cardiac failure and age [39, 40] . Myocyte cellular hywith the use of left ventricular mechanical supporting pertrophy is responsible for ventricular hypertrophy in devices in patients with end-stage cardiac failure reinhypertensive cardiomyopathy of middle age individuals in forced the concept that prolonged left ventricular unloadits compensated stage despite a significant loss of ing may improve ventricular and myocyte function and myocytes [39] . In contrast, cardiac hypertrophy of the aged reverse ventricular dilatation [44] . Although the recovery and senescent human heart in failure is characterized by an after the implantation of these devices is low, these data increased number of myocytes, dilatation of the ventricular together with those obtained with partial left ventriculeccavity and thinning of the wall [40] .
tomy recently used to treat patients with intractable dilated Hearts from patients in end-stage cardiac failure undercardiomyopathy in failure [45] confirm the early mechanisgoing cardiac transplantation, demonstrated extreme detic hypothesis that the stress per se is deleterious for grees of cardiac hypertrophy [41] [42] [43] . In ischemic [42] and myocytes. dilated cardiomyopathies [43] 
a 2-fold increase in myocar-
In experimental models a measurement of the amount of dial mass is associated with more than 4-fold increase in stress generated by ventricular dysfunction has been ventricular chamber volume, resulting in a significant obtained. In rats, acute and healed myocardial infarction reduction of muscle mass-to-chamber volume ratio. Acaffecting 60% or more of the left ventricular free wall, by cording to the law of Laplace, the circumferential diastolic combining functional and anatomical data the amount of stress per myocyte may be increased to unaffordable levels diastolic circumferential stress per myocyte layer within inducing myocyte cell death and explaining the irreverthe wall has been determined [46, 47] . In these conditions sibility of this pathology. Recently, in these end-stage wall stress increased more than 7-fold acutely and, after 1 failing hearts, myocyte apoptosis was documented and month, was almost 8-fold higher than in sham-operated found in an average of 2318 myocyte nuclei per million, a animals. Furthermore, ventricular dilatation was associated value 232-fold higher than controls [22] . These results with thinning of the wall brought about through lengthenwere coupled with alterations in the expression of meming of myocytes and transmural side-to-side slippage of bers of the Bcl-2 family of proteins: specifically, the level myofibers. Single or multiple myocyte cell death has been of Bcl-2, that promotes cell survival, increased in carpostulated to occur in order to permit the translocation of diomyopathies, whereas Bax, which induces apoptosis, myocyte bundles from the inner to the outer layer of the wall. This hypothesis has been verified in the papillary The assumption that a variety of mechanisms, other than muscle in vitro in which overstretching is associated with hemodynamic, are responsible for myocardial growth [1] [49] , in rats with aortic many others [73] that may influence myocardial growth banding [28] and several observations in humans [50] [51] [52] [53] without changes in load. At the same time in animals provided supportive evidences that apoptosis may be overexpressing a variety of factors such as MLP [74] , induced in the myocardium exposed to abnormal stress.
Galfaq [75] , tumor necrosis factor-a [76] or deprived of Finally, apoptotic myocyte cell death has been found to be different molecules such as Myo D [77] or ANP receptors increased in aged SHR and its amount is decreased by [78] , cardiac hypertrophy is associated with the develop-ACE treatment These results demonstrated again that ment of cardiac failure. The extent at which a single gene myocyte cell loss is an important determinant in the defect may simulate human cardiac hypertrophy, however, transition from compensated to decompensated cardiac remains to be determined. hypertrophy [54] .
It is of interest to note that the human heart may Although the signals that transduce the stimulus generincrease 2-to 3-fold in size under pathologic conditions ated by the physical forces from the sarcolemma to the ( Figs. 1 and 2 ) and myocytes hyperplasia must occur since nucleus and activate the genes responsible for apoptosis myocyte hypertrophy alone cannot account for such venare still unclear, recent observations suggest that myocyte tricular enlargement [11] . Other studies have reached cell death may be induced by substances that are activated similar conclusions [79] [80] [81] . In this regard, in dilated in animal models of cardiac hypertrophy [55] and in cardiomyopathic human hearts, despite the significant humans with heart failure [56] . Angiotensin II (Ang II) amount of connective tissue accumulation, the average was found to be able to increase the amount of apoptotic myocyte number was not reduced [43] , implying that cell death when added to enzymatically dissociated venmyocyte hyperplasia must have occurred. Furthermore, tricular myocytes from neonatal and adult rat hearts mitotic figures have been found in cardiac myocytes of [57, 58] . The mechanism by which the Ang II binding to humans with end-stage cardiac failure [82] , in pacing AT receptor induces DNA strand breaks appears to be induced cardiac failure in dogs [49] and in rat hearts after 1 related to the increase of intracellular calcium, which in myocardial infarction [83] . More recently, in hypertrophied turn activates a calcium-dependent endogenous endonuhearts above 500 g in weight, an increased number of clease. This apoptotic effect was drastically reduced by the mononucleated myocytes have been measured [84] . Addiaddition of AT receptor antagonist or chelating intracellutional examples of myocyte hyperplasia have been found 1 lar calcium [57] . In addition, in adult myocytes Ang II in humans and animals and different growth factors appear increases intracellular calcium through a protein kinase C to be able to stimulate myocyte hyperplasia in vivo and in mediated pathway [58] . Similarly, stimulation of beta vitro [85] [86] [87] [88] [89] [90] [91] . In this regard, the overexpression of IGF-1R adrenergic receptor with norepinephrine or isoproterenol in the heart of transgenic mice during the maturational induces apoptotic myocyte cell death in adult myocytes in growth resulted in myocardial hypertrophy associated with vitro [59] . This result is blocked by agents that inhibit an increased number of myocytes [92] . Finally, the overbeta-adrenergic receptors, protein kinase A and L-type expression of cyclin D1, a key regulatory factor for DNA calcium channels [59] . Furthermore, 24-h infusion of synthesis, in cardiomyocytes of transgenic mice [93, 94] isoproterenol in rats resulted in a significant number of and in aortic constricted rats [95] , during the development apoptic cardiomyocytes [60] . Atrial natriuretic peptide, of left ventricular hypertrophy, revealed sustained cytokines such as interleukin 1b, TNF-a and interferon g myocytes DNA synthesis. and nitric oxide are additional inducers of myocyte apop-
In conclusion, myocardial growth in response to modertosis [61, 62] .
ate or stressful conditions may not be dependent on It should be noted that some of the apoptotic agents increased afterload [1] and is associated with myocyte cell described above act as growth factors for neonatal and death by apoptosis, necrosis or both. Myocyte cell loss adult cardiomyocytes. In an attempt to explain these may represent the cause of the progressive evolution of contrasting data it has been suggested that in response to myocardial hypertrophy to ventricular failure. The reparabeta-adrenergic stimulation apoptotic signals prevail in tive process, the increased stress produced by the dilatation adult cells and an anti apoptotic / growing effect is apparent of the ventricular chamber and the thinning of the wall are in neonatal myocytes [59] . Several studies have demonadditional important factors limiting myocyte survival and strated that Ang II is a growth factor for myocytes via AT compensatory growth by hypertrophy and / or hyperplasia. 1 receptor, despite the apoptotic action [63] [64] [65] . In addition, Finally, it should be remembered that, although the growth hormone is able to stimulate myocyte cell growth efficacy demonstrated by different therapeutical treatments, [66] , but acromegalic cardiomyopathic hearts manifest only a few attempts were made to intervene directly on quite a large number of apoptotic myocyte cell death [67] .
cardiac dysfunction. The addition of new myocytes to the rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ failing heart is now possible and may give new avenues to Res 1986; 58:26-37. substitute myocyte cell lost [96, 97] . The use of sponta- we can prevent, avoid or, at least, delay the progression of 
